TELOMERE BIOLOGY DISORDERS
Clinical trials for TELOMERE BIOLOGY DISORDERS explained in plain language.
Never miss a new study
Get alerted when new TELOMERE BIOLOGY DISORDERS trials appear
Sign up with your email to follow new studies for TELOMERE BIOLOGY DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial aims to lengthen telomeres, offering hope for rare genetic diseases
Disease control Recruiting nowThis early-stage trial is testing whether a combination of two oral compounds (deoxycytidine and deoxythymidine) is safe for people with rare genetic disorders called telomere biology disorders. These disorders cause very short telomeres (protective caps on chromosomes), leading …
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE1 • Sponsor: Suneet Agarwal • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New transplant method aims to reduce dangerous side effects for rare blood disorders
Disease control Recruiting nowThis study is testing a modified stem cell transplant procedure for people with inherited bone marrow failure disorders like Fanconi anemia. The goal is to see if removing specific immune cells from the donor cells before transplant can reduce the risk of a serious complication c…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
20-Year quest to map the future of rare blood diseases
Knowledge-focused Recruiting nowThis study aims to understand the long-term health journey of people with rare bone marrow failure diseases. Researchers will follow 1,000 participants, including some family members, for up to 20 years to see how these diseases and their treatments affect the body over time. The…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC